Enliven Therapeutics, Inc. (ELVN): 4 filed Feb 17, 2026

Form type

4

Filing date

Feb 17, 2026

Accession number

0001654909-26-000001

Filer

Enliven Therapeutics, Inc. (CIK 1672619)